Adverse effect profile of trichlormethiazide: a retrospective observational study
Open Access
- 23 May 2011
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 10 (1) , 45
Abstract
Background: Trichlormethiazide, a thiazide diuretic, was introduced in 1960 and remains one of the most frequently used diuretics for treating hypertension in Japan. While numerous clinical trials have indicated important side effects of thiazides, e.g., adverse effects on electrolytes and uric acid, very few data exist on serum electrolyte levels in patients with trichlormethiazide treatment. We performed a retrospective cohort study to assess the adverse effects of trichlormethiazide, focusing on serum electrolyte and uric acid levels. Methods: We used data from the Clinical Data Warehouse of Nihon University School of Medicine obtained between Nov 1, 2004 and July 31, 2010, to identify cohorts of new trichlormethiazide users (n = 99 for 1 mg, n = 61 for 2 mg daily dosage) and an equal number of non-users (control). We used propensity-score matching to adjust for differences between users and control for each dosage, and compared serum chemical data including serum sodium, potassium, uric acid, creatinine and urea nitrogen. The mean exposure of trichlormethiazide of 1 mg and 2 mg users was 58 days and 64 days, respectively. Results: The mean age was 66 years, and 55% of trichlormethiazide users of the 1 mg dose were female. In trichlormethiazide users of the 2 mg dose, the mean age was 68 years, and 43% of users were female. There were no statistically significant differences in all covariates (age, sex, comorbid diseases, past drugs, and current antihypertensive drugs) between trichlormethiazide users and controls for both doses. In trichlormethiazide users of the 2 mg dose, the reduction of serum potassium level and the elevation of serum uric acid level were significant compared with control, whereas changes of mean serum sodium, creatinine and urea nitrogen levels were not significant. In trichlormethiazide users of the 1 mg dose, all tests showed no statistically significant change from baseline to during the exposure period in comparison with control. Conclusions: Our study showed adverse effects of decreased serum potassium and increased serum uric acid with trichlormethiazide treatment, and suggested that a lower dose of trichlormethiazide may minimize these adverse effects. These findings support the current trend in hypertension therapeutics to shift towards lower doses of thiazides.Keywords
This publication has 29 references indexed in Scilit:
- Chlorthalidone Reduces Cardiovascular Events Compared With HydrochlorothiazideHypertension, 2011
- Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical recordsCardiovascular Diabetology, 2010
- Combination therapy in hypertension: An updateDiabetology & Metabolic Syndrome, 2010
- Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a reviewCardiovascular Diabetology, 2009
- Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical recordsCardiovascular Diabetology, 2007
- Current Usage of Diuretics among Hypertensive Patients in Japan: The Japan Home versus Office Blood Pressure Measurement Evaluation (J-HOME) StudyHypertension Research, 2006
- Fixed-Dose Combinations in the Management of HypertensionAmerican Journal of Cardiovascular Drugs, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Randomized Double-Blind Comparison of a Calcium Antagonist and a Diuretic in Elderly HypertensivesHypertension, 1999
- A Double‐Blind, Randomized, Placebo‐Controlled Comparison of the Metabolic Effects of Low‐Dose Hydrochlorothiazide and IndapamideThe Journal of Clinical Pharmacology, 1991